Summary
Sixty-seven patients with acute nonlymphoblastic leukemia (ANLL) and above the age of 60 years were randomly allocated to treatment with either prednimustine+vincristine or cycles with cytosine arabinoside and thioguanine. Of the 67 patients, 13 (19%) entered a complete remission and four a partial remission. Of 33 patients randomized to prednimustine and vincristine (15 adequately treated), three entered a complete remission and one a partial remission. Four further patients went into complete remission after a switch to other treatment modalities. Of 34 patients randomized to cycles of ARA-C and thioguanine (22 adequately treated), four entered a complete remission and three a partial remission with the correct program. One patient entered a remission with intermittent cytosine arabinoside+thioguanine (wrong program) and one further patient entered a complete remission after a switch to prednimustine and vincristine. Prednimustine+vincristine did not appear to be superior to treatment with cytosine arabinoside thioguanine cycles for elderly patients with ANLL.
Similar content being viewed by others
References
Bodey GP, Coltman CA, Freireich EJ, et al. (1974) Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. Arch Intern Med 133:260
Brandt L, Könyves I (1977) Therapeutic effect of prednimustine (Leo 1031) in various types of leukaemia. Eur J Cancer 13:393
Brandt L, Könyves I (1979) Prednimustine in adult acute leukaemia. Cancer Chemother Pharmacol 2:133
Brandt L, Könyves I, Möller TR (1975) Therapeutic effect of Leo 1031, an alkylating corticosteroid ester in lymphoproliferative disorders. I. Chronic lymphocytic leukaemia. Acta Med Scand 197:317
Burge PS, Richards JDM, Thompson DS, et al. (1975) Quality and quantity of survival in acute myeloid leukaemia. Cancer 2:621
Crabtree GR, Smith KA, Munck A (1978) Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res 38:4268
Crosby WH (1968) To treat or not to treat granulocytic leukemia. Arch Intern Med 122:79
Crosby WH (1974) Grounds for optimism in treating acute granulocytic leukemia. Arch Intern Med 134:177
Crosby WH (1976) Acute granulocytic leukemia (AGL) in the elderly. Arch Intern Med 136:493
Evenaar AH, Wins EHR, Van Putten LM (1973) Cell killing effectiveness of an alkylating steroid (Leo 1031). Eur J Cancer 9:773
Guyer RJ, Winfield DA, Shahani RT, Blackburn EK (1971) Combination chemotherapy in acute myeloblastic leukemia. Br Med J 1:231
Håkansson L, Könyves I, Lindberg LG, Möller T (1978) Continuous treatment of non-Hodgkin's malignant lymphoma with Prednimustine (Leo 1031). Oncology 35:103
Hansson L-A, Gustafsson SA, Carlstedt-Duke J, Gahrton G, Högberg B, Gustafsson J-Å (1982) Glucocorticoid receptor content in leukemia cells. (in manus)
Ho AD, Hunstein W, Schmid W (1981) Glucocorticoid receptors and sensitivity in leukemias. Blut 42:183
Jensen HS, Hansen HH, Dombernowsky P (1980) Phase II trial of Prednimustine (NSC-124087) in the treatment of small-cell anaplastic carcinoma of the lung. Cancer Chemother Pharmacol 4:259
Juul K, Sørensen P, Pedersen-Bjergaard J, Krogh-Jensen M (1979) Phase II trial of Prednimustine, Leo-1031 (NSC-134087) in acute non-lymphocytic leukaemia. Scand J Haematol 23:388
Kontula K, Andersson LC, Paavonen T, Myllylä G, Teerenhovi L, Vuopio P (1980) Glucocorticoid receptors and glucocorticoid sensitivity of human leukemic cells. Int J Cancer 26:177
Könyves I, Liljekvist J (1976) The steroid molecule as a carrier of cytotoxic groups. Excerpta Medica, Amsterdam, p 98 (Int Congress Series no. 375)
Könyves I, Fex H, Högberg B (1974) Novel corticosteroid esters with alkylkating properties. In: Daikos GK (ed) Antineoplastic chemotherapy, vol III. Proc 8th Congr Chemotherapy, Athens, p 791
Lippman ME, Perry S, Thompson EB (1975) Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. Am J Med 59:224
Mandelli F, Amadori S, Fabiani F, Grignani F, Liso V, Martelli M, Neri A, Petti MC, Tonato M (1979) Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicenter study. Haematologica 64:331
Mattsson W, von Eyben F, Turesson I, Wahlby S (1978) Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histocytic lymphomas. Cancer 41:112
Medical Research Council's Working Party on leukaemia in Adults (1974) Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine,l-asparaginase, prednisone and thioguanine—Results of treatment with five multiple-drug schedules. Br J Haematol 27:373
Möller TR, Brandt L, Könyves I, Lindberg LG (1975) Therapeutic effect of Leo 1031, an alkylating corticosteroid ester in lymphoproliferative disorders. II. Lymphocytic lymphoma. Acta Med Scand 197:323
Mouridsen HT, Kristensen D, Halskov-Nielsen J, Dombernowsky P (1980) Phase II trial of Prednimustine, L-1031 (NSC-134087) in advanced breast cancer. Cancer 46:253
Pedersen-Bjergaard J, Mørk-Hansen M, Geisler CM, Nissen NI (1980) Clinical trial of Prednimustine, Leo 1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroid and alkylating agents. Acta Med Scand 207:215
Petersen BA, Bloomfield CD (1977) Treatment of acute nonlymphocytic leukemia in elderly patients. A prospective study of intensive chemotherapy. Cancer 40:647
Rubio LF Jr (19609) Acute leukemia in patients past the age of 50. J Am Geriatr Soc 8:644
Udén A-M, Brenning G, Engstedt L, et al. (1975)l-Asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. Scand J Haematol 15:72
Wiernik PH, Serpick AA (1970) Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL). Medicine (Baltimore) 49:505
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lönnqvist, B., Andersson, B., Björkholm, M. et al. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. Cancer Chemother. Pharmacol. 9, 89–92 (1982). https://doi.org/10.1007/BF00265385
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265385